Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MLYS
Stock Latest News
Stock Analysis & Ideas
Insiders Pour Millions into These 2 Stocks — Goldman Sachs Backs the Move
3d ago
SFD
MLYS
Premium
The Fly
Mineralys Therapeutics falls -4.9%
4d ago
MLYS
Premium
The Fly
Mineralys Therapeutics price target raised to $50 from $26 at Wells Fargo
8d ago
MLYS
Premium
Ratings
Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Phase 3 Results and Strong Financial Position
11d ago
MLYS
Premium
Ratings
Buy Rating Affirmed for Mineralys Therapeutics Due to Promising Hypertension Drug Data and Market Position
11d ago
MLYS
Premium
The Fly
Mineralys announces new subgroup analyses from Phase 3 Launch-HTN trial
14d ago
MLYS
Premium
Company Announcements
Mineralys Therapeutics Announces Public Offering of Shares
16d ago
8K
MLYS
Premium
The Fly
Mineralys Therapeutics 9.8M share Spot Secondary priced at $25.50
16d ago
MLYS
Premium
Company Announcements
Mineralys Therapeutics Halts Common Stock Offering
17d ago
8K
MLYS
Premium
The Fly
Mineralys Therapeutics announces $175M common stock offering
17d ago
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 9/2/2025, According to Top Analysts
17d ago
BBIO
MLYS
Premium
The Fly
Jefferies expects Mineralys stock to trade up following AstraZeneca data
17d ago
MLYS
Premium
Ratings
Buy Rating for Mineralys Therapeutics Driven by Competitive Position and Strategic Milestones
17d ago
MLYS
Premium
Company Announcements
Mineralys Therapeutics, Inc. Earnings Call Highlights
18d ago
MLYS
Premium
The Fly
Mineralys Therapeutics price target raised to $43 from $38 at BofA
22d ago
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 8/14/2025, According to Top Analysts
1M ago
BTM
EXE
Premium
Ratings
Positive Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Lorundrostat Outcomes and Strong Financial Position
1M ago
MLYS
Premium
Ratings
Buy Rating on Mineralys Therapeutics: Promising Outcomes for Lorundrostat in Hypertension and Beyond
1M ago
MLYS
Premium
Company Announcements
Mineralys Therapeutics Reports Positive Q2 2025 Results
1M ago
MLYS
Premium
Pre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
1M ago
MLYS
Premium
Market News
3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts
2M ago
MLYS
PRAX
Premium
Ratings
Promising Investment Opportunity in Mineralys Therapeutics Driven by Lorundrostat’s Clinical Success
2M ago
MLYS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
